US BANCORP \DE\ - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$32,155
-31.0%
5,900
-15.0%
0.00%
Q2 2023$46,581
-24.5%
6,942
-0.7%
0.00%
Q1 2023$61,722
+21.9%
6,990
+5.5%
0.00%
Q4 2022$50,638
-32.5%
6,628
-37.3%
0.00%
Q3 2022$75,000
-73.8%
10,566
-70.1%
0.00%
-100.0%
Q2 2022$286,000
-57.6%
35,310
-27.3%
0.00%0.0%
Q1 2022$674,000
-50.4%
48,592
+0.3%
0.00%
-50.0%
Q4 2021$1,359,000
+2.0%
48,435
+23.6%
0.00%
-33.3%
Q3 2021$1,332,000
-13.1%
39,202
+4.5%
0.00%0.0%
Q2 2021$1,533,000
+38.0%
37,523
+35.9%
0.00%
+50.0%
Q1 2021$1,111,000
-23.6%
27,617
+12.2%
0.00%
-33.3%
Q4 2020$1,455,000
+20.2%
24,608
-1.1%
0.00%0.0%
Q3 2020$1,210,000
+9.3%
24,872
+8.7%
0.00%0.0%
Q2 2020$1,107,000
+371.1%
22,880
+170.2%
0.00%
+200.0%
Q1 2020$235,0008,468
+846700.0%
0.00%
Q4 2019$010.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders